IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2847
-0.0003 (-0.11%)
Apr 1, 2025, 4:00 PM EST - Market closed
IGC Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IGC Pharma stock have an average target of 3.88, with a low estimate of 3.50 and a high estimate of 4.25. The average target predicts an increase of 1,262.84% from the current stock price of 0.28.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IGC Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Alliance Global Partners | Alliance Global Partners | Strong Buy Reiterates $3.5 | Strong Buy | Reiterates | $3.5 | +1,129.36% | Mar 6, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $4 → $4.25 | Strong Buy | Maintains | $4 → $4.25 | +1,392.80% | Feb 24, 2025 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.75 → $4 | Strong Buy | Maintains | $3.75 → $4 | +1,304.99% | Dec 5, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.5 → $3.75 | Strong Buy | Maintains | $3.5 → $3.75 | +1,217.18% | Sep 3, 2024 |
Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3.25 → $3.5 | Strong Buy | Maintains | $3.25 → $3.5 | +1,129.36% | Jul 29, 2024 |
Financial Forecast
Revenue This Year
1.24M
from 1.35M
Decreased by -7.96%
Revenue Next Year
1.47M
from 1.24M
Increased by 18.34%
EPS This Year
-0.09
from -0.22
EPS Next Year
-0.09
from -0.09
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 1.3M | 1.6M | 1.6M |
Avg | 1.2M | 1.5M | 1.5M |
Low | 1.2M | 1.4M | 1.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | -2.3% | 27.3% | 7.5% |
Avg | -8.0% | 18.3% | 3.4% |
Low | -12.6% | 10.8% | 0.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.07 | -0.07 | -0.09 |
Avg | -0.09 | -0.09 | -0.09 |
Low | -0.10 | -0.11 | -0.09 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.